Ionis Pharma (IONS) Misses Q3 EPS by 2c

Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $110.9 million versus the consensus estimate of $113.09 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• Hesai Group (HSAI) Tops Q1 EPS by 8c
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue